Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Thanchanit Thaipitakwong is currently a Senior Content Creator at HITAP, responsible for planning and delivering research communication to the public and developing content in various formats tailored to different audiences and platforms. With a background in pharmacy and experience in medical communication, she focuses on making complex academic c

Katika Akksilp MD PhD is a researcher at the Institute of Medical Research and Technology Assessment and currently serves as Head of the Precise Interventions (PI) unit at Health Intervention and Technology Assessment Program (HITAP) Foundation. He earned his doctorate in Public Health Research from Saw Swee Hock School of Public Health, National U

Shiela is an Associate at the HITAP International Unit. She holds a doctoral degree in Microbiology and currently leads antimicrobial resistance (AMR)-related projects at HITAP, in collaboration with international partners such as the University of Oxford, City St George’s University of London, and global organizations including the World Health Or

Jarawee Sukmanee is a researcher at the Health Intervention and Technology Assessment Program Foundation (HITAP). With a background as a medical doctor and epidemiologist, she applies advanced analytical techniques to evaluate the cost-effectiveness of health interventions. She plays a key role in generating evidence to support national policy deci

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo

The Post Graduate Institute of Medical Education and Research (PGIMER) requested HITAP to provide technical support to a national workshop on the use of economic evaluation analyses and research for decision making in healthcare in India. The workshop ran for four days and covered the differen

India is setting up a priority setting unit called the Medical Technology Assessment Board (MTAB) under the Department of Health Research (DHR) in the Ministry of Health and Family Welfare (MoHFW), Government of India. The International Decision Support Initiative (iDSI) is working with DHR in its e